Gerdau Reports Q4 Earnings Decline and R$2.0B Impairment, Approves New Share Buyback
Summary
Gerdau reported a significant decline in Q4 adjusted net income and a R$2.0 billion asset impairment in Brazil, though North American operations remained strong and the company approved a new share buyback program.
Key Events
-
Q4 and Full-Year 2025 Financial Performance
Consolidated Adjusted EBITDA for 4Q25 was R$2.4 billion, down 13.3% from 3Q25. Adjusted Net Income for 4Q25 totaled R$670 million, a 38.5% decrease quarter-over-quarter. For the full year 2025, Adjusted EBITDA was R$10.1 billion (down 7.1% YoY) and Adjusted Net Income was R$3.4 billion (down 21.1% YoY).
-
Significant Asset Impairment Loss
Gerdau recorded R$2.0 billion in non-cash asset impairment losses in 4Q25 related to assets in the Brazil Segment, reflecting a deterioration in economic conditions and asset utilization levels.
-
New Share Buyback Program Approved
The Board of Directors approved a new share buyback program for up to 55 million preferred shares and 1.4 million common shares, representing 2.9% of outstanding shares, with an 18-month term. This follows the completion of the 2025 program which acquired 3.0% of outstanding shares.
-
Dividend Distribution Approved
The company approved a dividend distribution of R$0.10 per share for 4Q25, totaling R$197.5 million, to be paid on March 18, 2026.
Analysis
Gerdau's fourth-quarter and full-year 2025 results reflect a challenging environment, particularly in Brazil, which saw a significant R$2.0 billion non-cash asset impairment. This impairment, representing a substantial portion of the company's market capitalization, indicates a re-evaluation of asset values and future economic conditions in the Brazilian segment. Despite strong performance from North American operations, consolidated adjusted net income declined sharply quarter-over-quarter and year-over-year. However, the company's commitment to shareholder returns remains evident with the approval of a new share buyback program for nearly 3% of outstanding shares and a dividend distribution, supported by a healthy leverage ratio. Investors should monitor the impact of trade defense measures in Brazil and the ramp-up of new CAPEX projects.
At the time of this filing, GGB was trading at $4.12 on NYSE in the Manufacturing sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $2.27 to $4.66. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.